Stay updated on T-DXd in HER2 Expressing Tumors Clinical Trial
Sign up to get notified when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.

Latest updates to the T-DXd in HER2 Expressing Tumors Clinical Trial page
- Check4 days agoChange DetectedThe recruitment location entry was updated from Gūrgaon, India, 122001 to Gurgaon, India, 122001.SummaryDifference0.0%

- Check11 days agoChange DetectedAdded study site Gūrgaon, India (122001) to the Locations list and updated the revision from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check18 days agoChange DetectedAdded Gurgaon, India, 122001 as a location and removed Gūrgaon, India, 122001 as a location.SummaryDifference0.0%

- Check32 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2, a minor label change with no impact on page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedThe India location entry was updated from Gurgaon, India, 122001 to Gūrgaon, India, 122001.SummaryDifference0.0%

- Check54 days agoChange DetectedThe changes consist of updated metadata timestamps (2026-01-21, 2026-01-20, 2026-01) and a new 'Last Update Posted' entry. The core study content, including eligibility, cohorts, and endpoints, remains unchanged.SummaryDifference0.1%

Stay in the know with updates to T-DXd in HER2 Expressing Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.